Verve Therapeutics, Inc. VERV
Trading inactive
| Name of reporting person | Citizenship or organization | Sole voting power | Shared voting power | Sole dispositive power | Shared dispositive power | Amount beneficially owned | Percent of class | Accepted date |
|---|---|---|---|---|---|---|---|---|
| BVF Partners OS Ltd. | Delaware | 0 | 0 | 0 | 359453 | 359453 | 1 % | 18/11/2024 |
| BVF Partners L.P. | Delaware | 0 | 0 | 0 | 6904050 | 6904050 | 8.2 % | 18/11/2024 |
| Biotechnology Value Fund, L.P. | Delaware | 0 | 0 | 0 | 3545349 | 3545349 | 4.2 % | 18/11/2024 |
| BVF GP Holdings LLC | Delaware | 0 | 0 | 0 | 6408382 | 6408382 | 7.6 % | 18/11/2024 |
| BVF Partners OS Ltd. | Delaware | 0 | 0 | 0 | 359453 | 359453 | 1 % | 18/11/2024 |
| BVF Inc. | Delaware | 0 | 0 | 0 | 6904050 | 6904050 | 8.2 % | 18/11/2024 |
| Mark N. Lampert | Delaware | 0 | 0 | 0 | 6904050 | 6904050 | 8.2 % | 18/11/2024 |
| BVF I GP LLC | Delaware | 0 | 0 | 0 | 3545349 | 3545349 | 4.2 % | 18/11/2024 |
| Biotechnology Value Fund II, L.P. | Delaware | 0 | 0 | 0 | 2863033 | 2863033 | 3.4 % | 18/11/2024 |
| BVF II GP LLC | Delaware | 0 | 0 | 0 | 2863033 | 2863033 | 3.4 % | 18/11/2024 |
| BVF I GP LLC | Delaware | 0 | 0 | 0 | 3545349 | 3545349 | 4.2 % | 18/11/2024 |
| Biotechnology Value Fund II, L.P. | Delaware | 0 | 0 | 0 | 2863033 | 2863033 | 3.4 % | 18/11/2024 |
| BVF II GP LLC | Delaware | 0 | 0 | 0 | 2863033 | 2863033 | 3.4 % | 18/11/2024 |
| Biotechnology Value Trading Fund OS LP | Delaware | 0 | 0 | 0 | 359453 | 359453 | 1 % | 18/11/2024 |
| BVF GP Holdings LLC | Delaware | 0 | 0 | 0 | 6408382 | 6408382 | 7.6 % | 18/11/2024 |
| BVF Partners L.P. | Delaware | 0 | 0 | 0 | 6904050 | 6904050 | 8.2 % | 18/11/2024 |
| BVF Inc. | Delaware | 0 | 0 | 0 | 6904050 | 6904050 | 8.2 % | 18/11/2024 |
| Biotechnology Value Fund, L.P. | Delaware | 0 | 0 | 0 | 3545349 | 3545349 | 4.2 % | 18/11/2024 |
| Mark N. Lampert | Delaware | 0 | 0 | 0 | 6904050 | 6904050 | 8.2 % | 18/11/2024 |
| Biotechnology Value Trading Fund OS LP | Delaware | 0 | 0 | 0 | 359453 | 359453 | 1 % | 18/11/2024 |
| STATE STREET CORPORATION | MA | 0 | 4060913 | 0 | 0 | 4253217 | 5 % | 16/10/2024 |
| Israel A. Englander | Delaware | 0 | 4301005 | 0 | 4301005 | 4301005 | 5.1 % | 27/06/2024 |
| Israel A. Englander | Delaware | 0 | 4301005 | 0 | 4301005 | 4301005 | 5.1 % | 27/06/2024 |
| Millennium Group Management LLC | Delaware | 0 | 4301005 | 0 | 4301005 | 4301005 | 5.1 % | 27/06/2024 |
| Millennium Management LLC | Delaware | 0 | 4301005 | 0 | 4301005 | 4301005 | 5.1 % | 27/06/2024 |
| Millennium Group Management LLC | Delaware | 0 | 4301005 | 0 | 4301005 | 4301005 | 5.1 % | 27/06/2024 |
| Millennium Management LLC | Delaware | 0 | 4301005 | 0 | 4301005 | 4301005 | 5.1 % | 27/06/2024 |
| (1) BlackRock, Inc. | Delaware | 4326548 | 0 | 4435481 | 0 | 4435481 | 5.6 % | 29/01/2024 |
| (1) BlackRock, Inc. | Delaware | 3491867 | 0 | 3594074 | 0 | 3594074 | 5.8 % | 10/02/2023 |
| ARK Investment Management LLC | 4270828 | 50694 | 4365830 | 0 | 4365830 | 7.09 % | 10/02/2023 | |
| The Vanguard Group - 23-1945930 | 0 | 38131 | 3743405 | 68619 | 3812024 | 6.19 % | 09/02/2023 | |
| STATE STREET CORPORATION | BOSTON, MASSACHUSETTS | 0 | 4393661 | 0 | 4471049 | 4471049 | 7.26 % | 07/02/2023 |
| SSGA FUNDS MANAGEMENT, INC. | BOSTON, MASSACHUSETTS | 0 | 3618546 | 0 | 3628546 | 3628546 | 5.89 % | 07/02/2023 |
| GV 2017, L.P. | Delaware | 6320905 | 6320905 | 6320905 | 6320905 | 6320905 | 13.12 % | 14/02/2022 |
| GV 2017, L.P. | Delaware | 6320905 | 0 | 6320905 | 0 | 6320905 | 13.12 % | 14/02/2022 |
| GV 2017 GP, L.P. | Delaware | 6320905 | 0 | 6320905 | 0 | 6320905 | 13.12 % | 14/02/2022 |
| GV 2017 GP, L.L.C. | Delaware | 6320905 | 0 | 6320905 | 0 | 6320905 | 13.12 % | 14/02/2022 |
| GV 2019 GP, L.L.C. | Delaware | 4472509 | 0 | 4472509 | 0 | 4472509 | 9.28 % | 14/02/2022 |
| XXVI Holdings Inc. | Delaware | 10974011 | 0 | 10974011 | 0 | 10974011 | 22.78 % | 14/02/2022 |
| Alphabet Holdings LLC | Delaware | 10793414 | 0 | 10793414 | 0 | 10793414 | 22.41 % | 14/02/2022 |
| Alphabet Inc. | Delaware | 10974011 | 0 | 10974011 | 0 | 10974011 | 22.78 % | 14/02/2022 |
| Verily Life Sciences LLC | Delaware | 180597 | 0 | 180597 | 0 | 180597 | 0.37 % | 14/02/2022 |
| GV 2019, L.P. | Delaware | 4472509 | 0 | 4472509 | 0 | 4472509 | 9.28 % | 14/02/2022 |
| GV 2019 GP, L.P. | Delaware | 4472509 | 0 | 4472509 | 0 | 4472509 | 9.28 % | 14/02/2022 |
| Casdin Partners Master Fund, L.P. | 0 | 2517596 | 0 | 2517596 | 2517596 | 5.2 % | 14/02/2022 | |
| Casdin Partners Master Fund, L.P. | 0 | 2517596 | 0 | 2517596 | 2517596 | 5.2 % | 14/02/2022 | |
| Casdin Partners GP, LLC | 0 | 2517596 | 0 | 2517596 | 2517596 | 5.2 % | 14/02/2022 | |
| Casdin Capital, LLC | 0 | 3138167 | 0 | 3138167 | 3138167 | 6.5 % | 14/02/2022 | |
| Eli Casdin | 0 | 3138167 | 0 | 3138167 | 3138167 | 6.5 % | 14/02/2022 | |
| Eli Casdin | 0 | 3138167 | 0 | 3138167 | 3138167 | 6.5 % | 14/02/2022 | |
| Casdin Capital, LLC | 0 | 3138167 | 0 | 3138167 | 3138167 | 6.5 % | 14/02/2022 | |
| Casdin Partners GP, LLC | 0 | 2517596 | 0 | 2517596 | 2517596 | 5.2 % | 14/02/2022 | |
| ARCH Venture Partners X, LLC | Delaware | 0 | 2508809 | 0 | 2508809 | 2508809 | 5.2 % | 09/02/2022 |
| ARCH Venture Fund X Overage, L.P. | 0 | 2508809 | 0 | 2508809 | 2508809 | 5.2 % | 09/02/2022 | |
| Kristina Burow | 0 | 2508809 | 0 | 2508809 | 2508809 | 5.2 % | 09/02/2022 | |
| Robert Nelsen | 0 | 2508809 | 0 | 2508809 | 2508809 | 2 % | 09/02/2022 | |
| ARCH Venture Partners X, LLC | 0 | 2508809 | 0 | 2508809 | 2508809 | 5.2 % | 09/02/2022 | |
| Kristina Burow | States of America | 0 | 2508809 | 0 | 2508809 | 2508809 | 5.2 % | 09/02/2022 |
| Gillis | United States of America | 0 | 2508809 | 0 | 2508809 | 2508809 | 2 % | 09/02/2022 |
| ARCH Venture Fund X, L.P. | Delaware | 0 | 2508809 | 0 | 2508809 | 2508809 | 5.2 % | 09/02/2022 |
| ARCH Venture Fund X Overage, L.P. | Delaware | 0 | 2508809 | 0 | 2508809 | 2508809 | 5.2 % | 09/02/2022 |
| ARCH Venture Partners X, L.P. | Delaware | 0 | 2508809 | 0 | 2508809 | 2508809 | 5.2 % | 09/02/2022 |
| ARCH Venture Partners X Overage, L.P. | Delaware | 0 | 2508809 | 0 | 2508809 | 2508809 | 5.2 % | 09/02/2022 |
| Crandell | 0 | 2508809 | 0 | 2508809 | 2508809 | 5.2 % | 09/02/2022 | |
| ARCH Venture Fund X, L.P. | 0 | 2508809 | 0 | 2508809 | 2508809 | 5.2 % | 09/02/2022 | |
| Crandell | United States of America | 0 | 2508809 | 0 | 2508809 | 2508809 | 5.2 % | 09/02/2022 |
| Robert Nelsen | United States of America | 0 | 2508809 | 0 | 2508809 | 2508809 | 2 % | 09/02/2022 |
| Gillis | 0 | 2508809 | 0 | 2508809 | 2508809 | 2 % | 09/02/2022 | |
| ARCH Venture Partners X, L.P. | 0 | 2508809 | 0 | 2508809 | 2508809 | 5.2 % | 09/02/2022 | |
| ARCH Venture Partners X Overage, L.P. | 0 | 2508809 | 0 | 2508809 | 2508809 | 5.2 % | 09/02/2022 | |
| Wellington Group Holdings LLP | Delaware | 0 | 3593866 | 0 | 0 | 3939508 | 8.18 % | 04/02/2022 |
| Wellington Management Group LLP | 0 | 3593866 | 0 | 0 | 3939508 | 8.18 % | 04/02/2022 | |
| Wellington Group Holdings LLP | 0 | 3593866 | 0 | 0 | 3939508 | 8.18 % | 04/02/2022 | |
| Wellington Management Group LLP | Massachusetts | 0 | 3593866 | 0 | 0 | 3939508 | 8.18 % | 04/02/2022 |
| Wellington Investment Advisors Holdings LLP | Delaware | 0 | 3593866 | 0 | 0 | 3939508 | 8.18 % | 04/02/2022 |
| Wellington Investment Advisors Holdings LLP | 0 | 3593866 | 0 | 0 | 3939508 | 8.18 % | 04/02/2022 | |
| Wellington Management Company LLP | Delaware | 0 | 3495171 | 0 | 0 | 3544908 | 7.36 % | 04/02/2022 |
| Wellington Management Company LLP | 0 | 3495171 | 0 | 0 | 3544908 | 7.36 % | 04/02/2022 | |
| Wellington Biomedical Innovation Master Investors (Cayman) I L.P. | 0 | 1871679 | 0 | 0 | 1871679 | 3.89 % | 04/02/2022 | |
| Wellington Biomedical Innovation Master Investors (Cayman) I L.P. | 0 | 1871679 | 0 | 0 | 1871679 | 3.89 % | 04/02/2022 | |
| FMR LLC | Delaware | 1503398 | 0 | 4841725 | 0 | 4841725 | 10.051 % | 28/12/2021 |
| Wellington Biomedical Innovation Master Investors (Cayman) I L.P. | 0 | 2495571 | 0 | 0 | 2495571 | 5.18 % | 28/06/2021 | |
| Wellington Biomedical Innovation Master Investors (Cayman) I L.P. | 0 | 2495571 | 0 | 0 | 2495571 | 5.18 % | 28/06/2021 | |
| Eli Casdin | Delaware | 0 | 3038167 | 0 | 3038167 | 3038167 | 6.6 % | 23/06/2021 |
| Casdin Partners GP, LLC | Delaware | 0 | 2417596 | 0 | 2417596 | 2417596 | 5.2 % | 23/06/2021 |
| Casdin Partners GP, LLC | Delaware | 0 | 2417596 | 0 | 2417596 | 2417596 | 5.2 % | 23/06/2021 |
| Casdin Partners Master Fund, L.P. | Delaware | 0 | 2417596 | 0 | 2417596 | 2417596 | 5.2 % | 23/06/2021 |
| Casdin Capital, LLC | Delaware | 0 | 3038167 | 0 | 3038167 | 3038167 | 6.6 % | 23/06/2021 |
| Eli Casdin | Delaware | 0 | 3038167 | 0 | 3038167 | 3038167 | 6.6 % | 23/06/2021 |
| Casdin Capital, LLC | Delaware | 0 | 3038167 | 0 | 3038167 | 3038167 | 6.6 % | 23/06/2021 |
| Casdin Partners Master Fund, L.P. | Delaware | 0 | 2417596 | 0 | 2417596 | 2417596 | 5.2 % | 23/06/2021 |
| Abigail P. Johnson | Delaware | 0 | 0 | 3319462 | 0 | 3319462 | 7.198 % | 23/06/2021 |
| FMR LLC | Delaware | 1490230 | 0 | 3319462 | 0 | 3319462 | 7.198 % | 23/06/2021 |
| FMR LLC | Delaware | 1490230 | 0 | 3319462 | 0 | 3319462 | 7.198 % | 23/06/2021 |
| Abigail P. Johnson | Delaware | 0 | 0 | 3319462 | 0 | 3319462 | 7.198 % | 23/06/2021 |